Savicell

Savicell is a pioneering biotechnology research company dedicated to early disease detection. With its innovative ImmunoBiopsy™ platform, Savicell focuses on identifying diseases at their earliest stages, significantly improving patient outcomes. The company's Well-Shield™ platform is a blood test designed for early disease detection, with an initial focus on addressing the multi-billion dollar cancer liquid biopsy market.

Located at MATAM Advanced Technology Park, Haifa, Israel 3190501, Savicell leverages metabolic changes within the immune system to modulate cell fate and function, thereby influencing immune response outcomes. Its Liquid ImmunoBiopsy measures energy changes of the immune system, identifying disease-specific ailments such as cancers, autoimmune diseases, and infectious diseases.

Savicell is committed to advancing healthcare through cutting-edge research and development. This commitment ensures that Savicell remains at the forefront of biotechnology, offering solutions for early disease detection and treatment tracking. We invite the management team at Savicell to create a customized and exclusive company showcase and product listing on our platform, highlighting their innovative work and contributing to a healthier future.